Targeting the DNA Damage Response in OSCC with TP53 Mutations.

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Oral squamous cell carcinoma (OSCC) is a prevalent cancer with poor survival rates.
• Tobacco, alcohol, and betel nut use are key risk factors for OSCC.
• Current treatments like radiotherapy and chemotherapy show limited efficacy in improving overall survival.

Purpose of the Study:

• To investigate the role of TP53 gene mutations in OSCC.
• To explore the association between TP53 mutations and treatment outcomes in OSCC patients.
• To identify novel therapeutic strategies targeting TP53 mutant OSCC.

Main Methods:

• Whole-exome sequencing to identify TP53 mutations in OSCC.
• Analysis of clinical data correlating TP53 mutation status with survival and treatment response.
• Review of DNA damage response pathways and potential therapeutic targets.

Main Results:

• TP53 mutations are frequently observed in human papillomavirus-negative OSCC.
• TP53 mutations are associated with poorer survival and resistance to radiotherapy and chemotherapy.
• The DNA damage response pathway, involving ATM, ATR, Chk1/2, and Wee1, is activated by DNA damage.

Conclusions:

• TP53 mutation status is a potential prognostic and predictive marker in OSCC.
• Targeting DNA repair and replication stress pathways presents a promising therapeutic avenue.
• Developing drugs that restore wild-type p53 activity could benefit OSCC patients with mutant p53 tumors.